Abstract
The invention relates to products and methods for transdifferentiating oligodendrocytes and/or oligodendrocyte precursor cells to neurons. The invention further relates to methods of treating central nervous system disorders and conditions.
Full Text
What is claimed is:
The invention relates to products and methods for transdifferentiating oligodendrocytes and/or oligodendrocyte precursor cells to neurons. The invention further relates to methods of treating central nervous system disorders and conditions.
Timeline
Filed
05/11/2026Published
09/03/2026Granted
Not AvailableIPC Codes(13)
A61K 35/76:Viruses; Subviral particles; Bacteriophages
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 31/7105:Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links